Laurus Labs board to meet on Oct 29 for Q2 results and interim dividend

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹2060.00

prior close

₹2049.00

announcement price

After-mkt

timing

Nifty Midcap 150market-0.0%-1.5% vs market

Pharmaceuticals peers, median of 172sector+0.0%-1.5% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Midcap 150 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.5

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.0-1.5+0.0-1.5

Next day

-2.0-0.3-1.7-0.8-1.2

+0.0-0.4+0.4-0.6+0.6

+0.4-1.5+1.9-1.9+2.3

-2.3-2.9+0.6-3.5+1.2

-2.8-3.7+0.9-4.4+1.6

-0.1-4.7+4.6-4.4+4.3

15d

+13.5+2.1+11.4-0.7+14.2

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laurus Labs has informed stock exchanges that its Board of Directors will meet on October 29, 2026 to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The Board will also consider a proposal for payment of an Interim Dividend for FY 2026-27 and fix the record date if approved. The trading window for insiders is already closed until October 31, 2026.

Likely market impact

Investors await Q2 FY26 numbers and any declared interim dividend, which could drive near-term stock action.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹2,206 Cr	₹1,653 Cr	+33.4%
Operating profit	₹578.8 Cr	₹242.8 Cr	+138.4%
Profit after tax	₹436.2 Cr	₹194.5 Cr	+124.3%
EBITDA margin	34.0%	24.4%	+9.6 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.